Finding the right CDMO partner for cell line development
Drug Target Review
APRIL 5, 2024
Together, these attributes provide a strong foundation for protein expression with enough adaptability to produce much of the commercial and therapeutic protein market. Prior to the operational consolidation with KBI, Séverine held multiple leadership roles with escalating responsibilities at Selexis.
96 
Let's personalize your content